Neuroblastoma Panel - Disclosures
Panel Member
|
Sahaja Acharya MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Jennifer Aldrink MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Jenna Allison MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Elizabeth Alva MD, MSPH |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Rochelle Bagatell MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Jennifer Belle MBA |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Daniel Benedetti MD, MA |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Marian Birkeland PhD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Nicole Blankenhorn |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Erin Brown MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Alanna Church MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Ami Desai MD, MSCE |
Equity Interest/Stock Options
|
| Pfizer Inc. | Viatris |
Date Completed
|
02/05/2025 |
Panel Member
|
Steven DuBois MD, MS |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Joaquim "Jack" Farinhas MD, MBA |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Kara Gill MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Kristina Gregory MSN, RN |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Evelyn Handel PharmD, BCOP, BCPS |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Lisa Hang PhD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Douglas Harrison MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Erin Hesler |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Frederick Huang MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Paul Iskander MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Susan Kreissman MD |
Equity Interest/Stock Options
|
| Belhaven Biopharma | Champions Oncology, Inc. |
Date Completed
|
12/17/2024 |
Panel Member
|
Daniel Lui PharmD, BCPPS |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Margaret Macy MD |
Equity Interest/Stock Options
|
| Johnson & Johnson |
Date Completed
|
04/07/2025 |
Panel Member
|
Svitlana Ostanina PhD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Julie Park MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Farzana Pashankar MD, MBBS, MRCP |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Praveen Pendyala MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Stephanie Polites MD, MPH |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Donna Powell DHSc, CMD, RT(T) |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Raja Rabah MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Ryan Schonfeld BA |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Hiroyuki Shimada MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Leonora Slatnick MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Elizabeth Sokol MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Samantha Tamburro BSN, RN, CPON |
Salary
|
| Flatiron Health, Inc. |
Date Completed
|
10/24/2024 |
Panel Member
|
Mark Tann MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Clare Twist MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Kieuhoa Vo MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Tanya Watt MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Suzanne Wolden MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Peter Zage MD, PhD |
Grant/Research Support
|
| Boundless Bio Inc | Exelixis Inc. |
Date Completed
|
10/21/2024 |